What Happened this Week? Nobel prize slips through CRISPR’s fingers, inside iGEM’s Jamboree and €120M boost for Alzheimer’s research

basil

Newsletter Signup - Under Article / In Page

"*" indicates required fields

Subscribe to our newsletter to get the latest biotech news!

By clicking this I agree to receive Labiotech's newsletter and understand that my personal data will be processed according to the Privacy Policy.*
This field is for validation purposes and should be left unchanged.

Monday: Manfred Horst on MSD, Biosimilars, KEYTRUDA and Merck & Co.’s rich history


Tuesday: An Insider’s experience at the iGEM Giant Boston Jamboree 2015


Wednesday: Sorry CRISPR, you’ll have to wait another year to win a Nobel Prize!


Thursday: The Future Biotech Lab Bench: My experience of the cutting edge-tech at LABVOLUTION


Friday: Alzheimer’s Disease: Phase III breakthrough Tau-therapy earns Scottish Biotech €120M